MedPath
NMPA Approval

Azelastine Hydrochloride Eye Drops

国药准字H20249403

November 15, 2024

Drug Information

盐酸氮䓬斯汀滴眼液

眼用制剂

0.05%(6ml:3mg)

化学药品

November 15, 2024

Company Information

Applicant Company

苏州工业园区东延路56号

Manufacturing Company

苏州工业园区东延路56号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸氮䓬斯汀滴眼液 - NMPA 批准文号 | MedPath